PT  - JOURNAL ARTICLE
AU  - Zunhammer, Matthias
AU  - Goltz, Gerrit
AU  - Schweifel, Maximilian
AU  - Stuck, Boris A.
AU  - Bingel, Ulrike
TI  - Savor the flavor — a randomized double-blind study on taste-enhanced placebo analgesia in healthy volunteers
AID  - 10.1101/2021.08.16.21262058
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.08.16.21262058
4099  - http://medrxiv.org/content/early/2021/08/17/2021.08.16.21262058.short
4100  - http://medrxiv.org/content/early/2021/08/17/2021.08.16.21262058.full
AB  - We conducted a randomized, double-blind, between-group study to investigate how the taste of oral medication affects placebo analgesia. Over three sub-studies, 318 healthy volunteers (297 included) were subjected to experimental tonic cold water pain (cold pressor test) before and after receiving taste-neutral (water), bitter (quinine), sweet (saccharine), or no placebo drops. Pain ratings indicated that taste enhances placebo analgesia. This effect was small but accounted for a substantial portion of the overall placebo effect and was comparable to WHO stage 1 analgesic effects. Moreover, placebo treatments were associated with an increase in peak heart rate response to cold water. Adverse effects were minimal. These results indicate that added taste may be an easy-to-implement, cost-effective, and safe way to optimize treatment outcomes and that taste-neutral preparations may reduce placebo-related outcome variance in clinical trials. Further studies are needed to test if these findings can be translated into clinical scenarios.Competing Interest StatementM.Z. is currently employed by Takeda Pharmaceutical. The company was not associated with the present study in any way. None of the authors has any conflict of interest to disclose.Clinical TrialThe study was registered in the German Clinical Trials Register (DRKS00011688), after the start of data collection.Funding StatementThis research was funded by the Mercator Research Center Ruhr (MERCUR) and the DFG research group 1328.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The present study was conducted in accordance with the Declaration of Helsinki, approved by the ethics committee of the University Hospital Essen (16-7163-BO and amendments).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe underlying data and analysis is available online at https://github.com/mzunhammer/analysis_placebo_taste. https://github.com/mzunhammer/analysis_placebo_taste